Tech Company Financing Transactions
REN Pharmaceuticals Funding Round
On 6/30/2008, REN Pharmaceuticals raised $1.5 million in funding from Sanderling Ventures.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
Sanderling Ventures (Paul Grayson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
270 E. Grand Ave.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
The company's mission is to develop and commercialize breakthrough therapeutics for renal diseases and associated cardio-renal diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Narachi
VP - Bus. Development
Angie You
Browse more venture capital transactions:
Prev: 6/30/2008: Spring2 Partners venture capital transaction
Next: 6/30/2008: Arasor venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs